Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Brazil: sales growth rate of Raia Drogasil 2013-2016

Sales growth rate of pharmaceutical company Raia Drogasil in Brazil between 2013 and 2016

by Marina Pasquali, last edited Jul 12, 2019
Brazil: sales growth rate of Raia Drogasil 2013-2016 This statistic presents the growth rate of net sales generated by the Brazilian pharmaceutical retailer Raia Drogasil S/A between 2013 and 2016. In 2016, the company's net sales increased by 10.5 percent, compared to the previous year.
Show more

Sales growth rate of pharmaceutical company Raia Drogasil in Brazil between 2013 and 2016

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Health in Brazil"
  • Overview
The most important statistics
  • Health risk factors
  • Mosquito-borne diseases
  • Health system & companies
  • Interaction with health services
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.